Company Filing History:
Years Active: 2009-2011
Title: Warwick Nesbitt: Innovator in Anti-Thrombotic Therapy
Introduction
Warwick Nesbitt is a notable inventor based in Victoria, Australia. He has made significant contributions to the field of medical research, particularly in the development of therapies aimed at treating thrombotic conditions. With a total of two patents to his name, his work is recognized for its potential impact on healthcare.
Latest Patents
Warwick's latest patents focus on the inhibition of phosphoinositide 3-kinase β. The present invention relates to selective inhibitors of phosphoinositide (PI) 3-kinase β, which are utilized in anti-thrombotic therapy. This invention also includes a method for screening compounds that are useful for new anti-thrombotic therapies by detecting the selective inhibitory activity of PI 3-kinase β. Additionally, the invention encompasses novel compounds that act as inhibitors of PI 3-kinase.
Career Highlights
Warwick Nesbitt is currently associated with AstraZeneca, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to innovative solutions in the medical field. His research is pivotal in advancing therapeutic options for patients suffering from thrombotic disorders.
Collaborations
Warwick has collaborated with esteemed colleagues such as Shaun P. Jackson and Alan Duncan Robertson. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical industry.
Conclusion
Warwick Nesbitt's contributions to the field of anti-thrombotic therapy through his patents and collaborations highlight his role as a significant inventor in medical research. His work continues to pave the way for advancements in treatment options for thrombotic conditions.